KLS Keeping Law Simple Legislation in plain English

Straight-ahead summaries built from the official bill text. We keep the source links front and center and leave the decision up to you.

Back to New Hampshire

SB650 • 2026

relative to use of cannabis products for therapeutic purposes by alternative treatment centers.

relative to use of cannabis products for therapeutic purposes by alternative treatment centers.

Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor
David Rochefort (R), Victoria Sullivan (R), Lucy Weber (D), Daniel Innis (R), Keith Murphy (R), Carol McGuire (R), Tim McGough (R), Yury Polozov (R), Karen Ebel (D)
Last action
2026-03-26
Official status
SENATE
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

relative to use of cannabis products for therapeutic purposes by alternative treatment centers.

relative to use of cannabis products for therapeutic purposes by alternative treatment centers.

What This Bill Does

  • relative to use of cannabis products for therapeutic purposes by alternative treatment centers.

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

  1. 2026-03-26 S

    Sen. Gannon Moved Laid on Table, MA, VV; 03/26/2026; SJ 7

  2. 2026-03-26 S

    Pending Motion Interim Study; 03/26/2026; SJ 7

  3. 2026-03-18 S

    Committee Report: Referred to Interim Study, 03/26/2026, Vote 3-1; SC 11

  4. 2026-02-05 S

    Hearing: 02/10/2026, Room 100, SH, 01:50 pm; SC 5A

  5. 2026-01-07 S

    Introduced 01/07/2026 and Referred to Judiciary; SJ 2

Official Summary Text

relative to use of cannabis products for therapeutic purposes by alternative treatment centers.

Current Bill Text

Read the full stored bill text 
SB 650 - AS INTRODUCED

2026 SESSION
26-2089
05/09

SENATE BILL
650

AN ACT
relative to use of cannabis products for therapeutic purposes by alternative treatment centers.

SPONSORS: Sen. Rochefort, Dist 1; Sen. Innis, Dist 7; Sen. McGough, Dist 11; Sen. Sullivan, Dist 18; Sen. Murphy, Dist 16; Rep. Polozov, Merr. 10; Rep. Weber, Ches. 5; Rep. C. McGuire, Merr. 27; Rep. Ebel, Merr. 7

COMMITTEE: Judiciary

-----------------------------------------------------------------

ANALYSIS

This bill permits alternative treatment centers to use certain cannabis products for therapeutic purposes.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Explanation: Matter added to current law appears in
bold italics.
Matter removed from current law appears [
in brackets and struckthrough.
]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
26-2089
05/09

STATE OF NEW HAMPSHIRE

In the Year of Our Lord Two Thousand Twenty-Six

AN ACT
relative to use of cannabis products for therapeutic purposes by alternative treatment centers.

Be it Enacted by the Senate and House of Representatives in General Court convened:

1 Use of Cannabis for Therapeutic Purposes; Definitions; Cannabis. Amend RSA 126-X:1, III to read as follows:
III. "Cannabis" means all parts of any plant of the Cannabis genus of plants, whether growing or not; the seeds thereof; the resin extracted from any part of such plant; and every compound, salt, derivative, mixture, or preparation of such plant, its seeds, or resin. Such term shall not include the mature stalks of such plants, fiber produced from such stalks, oil, or cake made from the seeds of such plants, any other compound, salt, derivative, mixture, or preparation of such mature stalks (except the resin extracted therefrom), fiber, oil or cake, or the sterilized seeds of such plants which are incapable of germination. In this chapter, cannabis shall not include hemp grown, processed, marketed, or sold under RSA 439-A
, except as provided in RSA 126-X:8, XIX
.

2 New Paragraph; Use of Cannabis for Therapeutic Purposes; Alternative Treatment Centers; Requirements. Amend RSA 126-X:8 by inserting after paragraph XVIII the following new paragraph:
XIX.(a) An alternative treatment center may acquire and may use in the manufacture of cannabis concentrate and cannabis-infused products, CBD, and other hemp-derived nonintoxicating cannabinoids not produced by an alternative treatment center in New Hampshire. All such non-intoxicating cannabinoids, and all cannabis concentrate and cannabis-infused products manufactured from such non-intoxicating cannabinoids, shall be tested for contaminants and cannabinoid profile in accordance with this chapter and department rules.
(b) An alternative treatment center shall not use products that are derived from hemp which contain natural tetrahydrocannabinol (THC) greater than 0.3 percent on a dry weight basis, which appear in any formulation, including delta-8 THC, delta-9 THC, or any other THC isomer variant, or which contain synthetic THC in any formulation and in any amount.

3 Effective Date. This act shall take effect 60 days after its passage.